Eloi Kpamegan

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

Gregory M. Glenn, Louis Fries, D. Nigel Thomas et al. · The Journal of Infectious Diseases · 2015 · 154 citations · Full text

Life Sciences, Immunology, Maternal Health +17

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Gregory M. Glenn, Gale Smith, Louis Fries et al. · Vaccine · 2012 · 143 citations

Veterinary Medicine, Immunology, Infectious Diseases +10

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice

Karin Lövgren Bengtsson, Haifeng Song, Linda Stertman et al. · Vaccine · 2016 · 131 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

Gale Smith, David C. Flyer, Rama Raghunandan et al. · Vaccine · 2013 · 109 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans

Surender Khurana, Jian Wu, Nitin Verma et al. · Journal of Virology · 2011 · 97 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17